Literature DB >> 7823067

Which factors predict cognitive decline in Parkinson's disease?

D Caparros-Lefebvre1, N Pécheux, V Petit, A Duhamel, H Petit.   

Abstract

The study assessed cognitive decline in non-demented, non-depressed patients with well defined Parkinson's disease and determined the predictive value for cognitive decline of different motor symptoms. Motor disability was measured with the Unified Parkinson's disease rating scale, impairment in activities of daily living, levodopa test, and long term clinical follow up. Neuropsychological evaluations included modified mini mental state, fluency, Wechsler logical memory, Wisconsin card sorting test, and the Montgomery and Asberg depression rating scale. Fifty three patients fulfilling clinical criteria for idiopathic Parkinson's disease were studied. Cognitive performance on initial testing was significantly correlated with education and disease duration but not with age at disease onset. Cognitive performance on retesting after three years of follow up was significantly reduced. This reduction was significantly greater in the late onset group, in patients with isolated dystonic dyskinesiae, and in patients with a lower percentage of motor improvement on levodopa. Cognitive decline in idiopathic Parkinson's disease may depend on both the prevalence of non-dopaminergic lesions and the topography of dopaminergic denervation. Predictive factors for cognitive decline, especially in executive tasks, relate more to non-dopaminergic than to dopaminergic lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7823067      PMCID: PMC1073268          DOI: 10.1136/jnnp.58.1.51

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

Review 1.  Parkinsonism-plus syndromes.

Authors:  J Jankovic
Journal:  Mov Disord       Date:  1989       Impact factor: 10.338

2.  Psychometric findings in clinical subtypes of Parkinson's disease.

Authors:  G Ransmayr; W Poewe; S Ploerer; G Birbamer; F Gerstenbrand
Journal:  Adv Neurol       Date:  1987

3.  Predictive factors for cognitive deterioration and dementia in Parkinson's disease.

Authors:  R Portin; U K Rinne
Journal:  Adv Neurol       Date:  1987

4.  Cognitive impairments in Parkinson's disease.

Authors:  J H Growdon; S Corkin
Journal:  Adv Neurol       Date:  1987

5.  The effect of age of disease onset on neuropsychological performance in Parkinson's disease.

Authors:  M Hietanen; H Teräväinen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

6.  Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.

Authors:  S M de la Monte; S E Wells; T Hedley-Whyte; J H Growdon
Journal:  Ann Neurol       Date:  1989-09       Impact factor: 10.422

7.  Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

Authors:  B Pillon; B Dubois; G Cusimano; A M Bonnet; F Lhermitte; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

8.  [The L-dopa test in Parkinson's disease].

Authors:  M Esteguy; A M Bonnet; J Kefalos; F Lhermitte; Y Agid
Journal:  Rev Neurol (Paris)       Date:  1985       Impact factor: 2.607

9.  Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test.

Authors:  B Pillon; B Dubois; A M Bonnet; M Esteguy; J Guimaraes; J M Vigouret; F Lhermitte; Y Agid
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

10.  Temporal ordering and short-term memory deficits in Parkinson's disease.

Authors:  H J Sagar; E V Sullivan; J D Gabrieli; S Corkin; J H Growdon
Journal:  Brain       Date:  1988-06       Impact factor: 13.501

View more
  9 in total

Review 1.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  D Aarsland; K Karlsen
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: which matters most?

Authors:  Francesca Di Biasio; Nicola Vanacore; Alfonso Fasano; Nicola Modugno; Barbara Gandolfi; Francesco Lena; Giovanni Grillea; Sara Pietracupa; Giovanni Caranci; Stefano Ruggieri
Journal:  J Neural Transm (Vienna)       Date:  2011-12-13       Impact factor: 3.575

Review 3.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

4.  Randomized trial of cognitive speed of processing training in Parkinson disease.

Authors:  Jerri D Edwards; Robert A Hauser; Melissa L O'Connor; Elise G Valdés; Theresa A Zesiewicz; Ergun Y Uc
Journal:  Neurology       Date:  2013-09-06       Impact factor: 9.910

5.  Effect of levodopa on frontal-subcortical and posterior cortical functioning in patients with Parkinson's disease.

Authors:  Amara Gul; Javed Yousaf
Journal:  Singapore Med J       Date:  2018-09-24       Impact factor: 1.858

6.  Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.

Authors:  Joana Meireles; João Massano
Journal:  Front Neurol       Date:  2012-05-25       Impact factor: 4.003

7.  Cognitive impairments in Parkinson's disease: Evidence from an Iranian population.

Authors:  Farzad Ashrafi; Alireza Zali; Hossein Pakdaman; Karim Johari
Journal:  Iran J Neurol       Date:  2012

8.  Progression of Cognitive Decline in Parkinson's Disease.

Authors:  Mandy Roheger; Elke Kalbe; Inga Liepelt-Scarfone
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

Review 9.  Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease.

Authors:  Shigeki Hirano
Journal:  Mol Med       Date:  2021-04-15       Impact factor: 6.354

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.